Funding the Cure
The Michael W. Oglesby Foundation works diligently to fund the cure for pancreatic cancer. With your help, we are able to contribute to Pancreatic Cancer Research at the University of Wisconsin-Madison Carbone Cancer Center. Research into prevention, early dedication, and treatment is vital in the fight against pancreatic cancer. Learn more about the UW Carbone Cancer Center here. Read on to learn about Dr. Sean Ronnekleiv-Kelly, who is leading essential research into factors that may influence the developement and aggressiveness of pancreatic cancer.
Assistant Professor
Division of Surgical Oncology
University of Wisconsin-Madison
Dr. Sean Ronnekleiv-Kelly
Dr. Sean Ronnekleiv-Kelly is an Assistant Professor in the Department of Surgery at the University of Wisconsin School of Medicine and Public Health (UW SMPH), Division of Surgical Oncology. His clinical focus is pancreas cancer and hepatobiliary cancers, and his research centers on evaluating how an 'environmental sensor' class of proteins affects pancreas cancer development and spread. He completed a surgical residency at UW SMPH and during that time recognized the complexity of cancer and the need for research to achieve breakthroughs for patients with cancer. He then completed a Complex General Surgical Oncology Fellowship at Johns Hopkins, where his extensive exposure to patients with pancreas and hepatobiliary cancer caused him to appreciate the limited therapeutic options available for these patients. In particular, he recognized that pancreas cancer was a malignancy where immense advancements in treatment are needed. Therefore, his laboratory focuses on manipulating the Per-Arnt-Sim family of 'environmental sensor' proteins, such as those involved in circadian rhythm, to improve preventive and therapeutic strategies for patients with pancreas cancer.